hVIVO plc
OPORFOTCHealthcare● Active
$0.35
+$0.26(+306.50%)
Market Cap$240940378
P/E Ratio—
52W High$0.35
52W Low$0.0861
hVIVO plc (OPORF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OPORF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 15, 2026EPS Actual
-$0.01
Revenue
$0.03B
Est. $0.06B · -49.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 15, 2026
After Market Close
▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
OPORF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 15, 2026 | — | — | — | — | — | — |
| — Q2 FY2026 | Apr 15, 2026 | — | -$0.01 | — | $0.03B | $0.06B | -49.1% |
| — Q2 FY2025 | Apr 7, 2025 | — | $0.01 | — | $0.03B | $0.03B | -3.1% |
| — Q3 FY2024 | Sep 10, 2024 | — | $0.01 | — | $0.05B | $0.05B | +4.6% |
| ▲ Q2 FY2024 | May 13, 2024 | $0.01 | $0.02 | +156.9% | $0.04B | $0.04B | +4.8% |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.01 | — | $0.03B | $0.04B | -5.1% |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.00 | — | $0.04B | $0.04B | +0.9% |
| — Q2 FY2022 | Jun 30, 2022 | — | $0.00 | — | $0.02B | — | — |
Q3 FY2026
Sep 15, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 15, 2026
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.03B
Q2 FY2025
Apr 7, 2025
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.03B
Q3 FY2024
Sep 10, 2024
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.05B
Q2 FY2024
May 13, 2024Beat
EPS Actual
$0.02
EPS Est.
$0.01
EPS Surpr.
+156.9%
Revenue
$0.04B
Q2 FY2023
Jun 30, 2023
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.03B
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.04B
Q2 FY2022
Jun 30, 2022
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | Apr 15, 2026 | — | $0.09 | $0.09 | +0.00% |
| — Q2 FY2025 | Apr 7, 2025 | — | $0.24 | $0.24 | +0.00% |
| — Q3 FY2024 | Sep 10, 2024 | — | $0.35 | $0.35 | +0.00% |
| ▲ Q2 FY2024 | May 13, 2024 | +156.9% | $0.35 | $0.35 | +0.00% |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.15 | $0.15 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.10 | $0.10 | +0.00% |
| — Q2 FY2022 | Jun 30, 2022 | — | $0.23 | $0.23 | +0.00% |
| — Q4 FY2021 | Dec 31, 2021 | — | $0.26 | $0.26 | +0.00% |
Q2 FY2026+0.00%
Report Date
Apr 15, 2026
EPS Beat/Miss
—
Price Before
$0.09
Price After
$0.09
Q2 FY2025+0.00%
Report Date
Apr 7, 2025
EPS Beat/Miss
—
Price Before
$0.24
Price After
$0.24
Q3 FY2024+0.00%
Report Date
Sep 10, 2024
EPS Beat/Miss
—
Price Before
$0.35
Price After
$0.35
Q2 FY2024+0.00%
Report Date
May 13, 2024
EPS Beat/Miss
+156.9%
Price Before
$0.35
Price After
$0.35
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$0.15
Price After
$0.15
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$0.10
Price After
$0.10
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$0.23
Price After
$0.23
Q4 FY2021+0.00%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$0.26
Price After
$0.26
Avg Beat Reaction+0.00%
Beat Rate1 / 8 quarters
Largest Move+0.00% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OPORF ends December
hVIVO plc (OPORF) most recently reported earnings on April 15, 2026 for Q2 FY2026, posting EPS of $-0.01 (in line with the analyst consensus of —). The next OPORF earnings date is expected around September 1, 2026.
Each quarter, investors track OPORF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OPORF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OPORF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OPORF earnings · 4 questionshVIVO plc's next earnings report is expected around September 1, 2026. OPORF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OPORF historically reports after market close (AMC).
OPORF earnings datewhen is OPORF earningsOPORF next earnings datewhen does OPORF report earningsOPORF earnings calendar
▸ Source: FMP · hVIVO plc SEC filings · US GAAP · hVIVO plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026